Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KRX/185750 stock hub

KRX/185750 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/185750is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.1T

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/185750

In the news

Latest news · KRX/185750

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E14.9

P25 9.8P50 17.1P75 31.9

Trailing P/E14.2

P25 12P50 23.1P75 39.5

ROE8.2

P25 -17.1P50 0.7P75 8.5

ROIC7.5

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/185750 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

230

Groups with data

Currency

KRW

Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	2,253
Enterprise value	KRW 1.1T
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KR7185750007
Last refreshed	2026-05-10
Market cap	KRW 1.1T
Price	KRW 82,800
Price currency	KRW
Rev Per Employee	751,177,979.2x
Sector	Healthcare
Sic	2834
Symbol	krx/185750
Website	https://www.ckdpharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.1%
EV Earnings	14.38x
EV/EBIT	13.84x
EV/EBITDA	8.89x
EV/FCF	-15.16x
EV/Sales	0.66x
FCF yield	-6.74%
Forward P/E	14.86x
P/B ratio	1.08x
P/E ratio	14.16x
P/S ratio	0.64x
PE Ratio10 Y	17.5x
PE Ratio3 Y	10.52x
PE Ratio5 Y	14.65x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	4.76%
EBITDA Margin	7.41%
Gross margin	31.1%
Gross Profit	KRW 526.4B
Gross Profit Growth	-1.17%
Gross Profit Growth Q	-0.05%
Gross Profit Growth3 Y	-1.01%
Gross Profit Growth5 Y	1.48%
Net Income	KRW 77.5B
Net Income Growth	-28.94%
Net Income Growth Q	220.39%
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Net Income Growth3 Y	-1.44%
Net Income Growth5 Y	-3.29%
Pretax Margin	4.82%
Profit Margin	4.58%
Profit Per Employee	KRW 34.4M
Profitable Years	10
ROA	3.09
Roa5y	6.38
ROCE	6.27
ROE	8.18
Roe5y	14.4
ROIC	7.5
Roic5y	15.29

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	2.08%
Cagr1y	4.95%
Cagr3y	2.42%
Cagr5y	-4.6%
Div CAGR10	-1.96%
Div CAGR3	-21.85%
Div CAGR5	-10.36%
EPS Growth	-29.01
EPS Growth Q	210.3
EPS Growth Quarters	2
EPS Growth Years	0
EPS Growth3 Y	-0.94
EPS Growth5 Y	-2.51
FCF Growth Q	627.56%
OCF Growth	4.78%
OCF Growth Q	276.28%
OCF Growth3 Y	-0.19%
OCF Growth5 Y	-8.38%
Revenue Growth	6.68x
Revenue Growth Q	2.75x
Revenue Growth Quarters	5x
Revenue Growth Years	1x
Revenue Growth3 Y	4.38x
Revenue Growth5 Y	5.37x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 1.04
Assets	KRW 1.8T
Cash	KRW 346.5B
Current Assets	KRW 1.1T
Current Liabilities	KRW 516.1B
Debt	KRW 367.8B
Debt EBITDA	KRW 2.93
Debt Equity	KRW 0.37
Debt FCF	KRW -5
Equity	KRW 1T
Interest Coverage	12.03
Liabilities	KRW 793.9B
Long Term Assets	KRW 708.5B
Long Term Liabilities	KRW 277.8B
Net Cash	KRW -21.3B
Net Cash By Market Cap	KRW -1.95
Net Debt EBITDA	KRW 0.17
Net Debt Equity	KRW 0.02
Tangible Book Value	KRW 913.7B
Tangible Book Value Per Share	KRW 69,347
WACC	4.8

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.12
Inventory Turnover	2.98
Net Working Capital	KRW 395.1B
Quick ratio	1.26
Working Capital	KRW 575.7B
Working Capital Turnover	KRW 2.89

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.5%
Dividend Growth	-54.55%
Dividend Growth Years	0%
Dividend per share	KRW 1,100
Dividend Years	13
Dividend Yield	1.33%
Ex Div Date	2025-12-29
Last Dividend	KRW 500
Payout Frequency	Annual
Payout Ratio	17.84%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	22.88%
1Y total return	4.94%
200-day SMA	85,277
3Y total return	7.42%
50-day SMA	87,786
50-day SMA vs 200-day SMA	50over200
5Y total return	-20.99%
All Time High	224,872
All Time High Change	-63.18%
All Time High Date	2020-12-21
All Time Low	36,684.7
All Time Low Change	125.71%
All Time Low Date	2015-01-21
ATR	2,102.1
Beta	0.29
Beta1y	0.51
Beta2y	0.41
Ch YTD	-0.12
High	83,800
High52	106,800
High52 Date	2025-07-29
High52ch	-22.47%
Low	82,100
Low52	78,100
Low52 Date	2025-05-13
Low52ch	6.02%
Ma50ch	-5.68%
Price vs 200-day SMA	-2.9%
RSI	34.8
RSI Monthly	46.05
RSI Weekly	43.87
Sharpe ratio	0.18x
Sortino ratio	0.46
Total Return	0.82%
Tr YTD	-0.12
Tr1m	-3.94%
Tr1w	-3.83%
Tr3m	-4.83%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 80.6B
Operating Income Growth	-19
Operating Income Growth Q	247.1
Operating Income Growth3 Y	-9.83
Operating Income Growth5 Y	-8.25
Operating margin	4.76

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7,634,005%
Net Borrowing	182,547,729,010
Shares Insiders	14.09%
Shares Institutions	27.29%
Shares Out	13,176,068
Shares Qo Q	4.11%
Shares Yo Y	0.5%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -73.6B
Average Volume	27,240.9x
Bv Per Share	76,180.1
CAPEX	KRW -140.9B
Ch10y	13.8
Ch1m	-3.94
Ch1w	-3.83
Ch1y	4.94
Ch3m	-4.83
Ch3y	5.29
Ch5y	-24.04
Ch6m	0.49
Change	-0.36%
Change From Open	-1.08
Close	83,100
Days Gap	0.72
Depreciation Amortization	44,797,838,000
Dollar Volume	1,916,406,000
Earnings Date	2026-05-04
EBIT	KRW 80.6B
EBITDA	KRW 125.4B
EPS	KRW 5,846
F Score	3
FCF	KRW -73.6B
FCF EV Yield	-6.6x
FCF Per Share	KRW -5,583
Financing CF	166,964,105,790
Fiscal Year End	December
Founded	1,941
Graham Number	100097.79081
Graham Upside	20.89
Income Tax	KRW 3.8B
Investing CF	-245,284,240,340
Is Primary Listing	1
Last Earnings Date	2026-02-02
Last Report Date	2025-12-31
Last Split Date	2024-12-27
Last Split Type	Forward
Lynch Fair Value	KRW 29,228
Lynch Upside	-64.7
Ma150	86,050.7
Ma150ch	-3.78%
Ma20	87,295
Ma20ch	-5.15%
Net CF	-12,233,974,840
Open	83,700
P OCF Ratio	16.2
Payment Date	2026-04-10
Position In Range	41.18
Ppne	437,693,766,480
Price Date	2026-05-08
Price EBITDA	KRW 8.7
Ptbv Ratio	1.19
Relative Volume	0.85x
Revenue	1,692,403,987,130x
Tax By Revenue	0.23x
Tax Rate	4.69%
Tr6m	0.49%
Volume	23,145
Z Score	2.87

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

KRX/185750 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.3%

$1100 annual per share

Payout ratio

+17.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-10.4%

0 consecutive years of growth

Total shareholder yield

+0.8%

Next ex-dividend date: 2025-12-29

Performance

KRX/185750 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRX/185750?

Insider, institutional, and short-interest positioning.

Institutional ownership

+27.3%

Share of float held by funds and institutions

Insider ownership

+14.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.5%

Negative means the company is buying back shares.

Technical

KRX/185750 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

34.8

Neutral momentum band

Price vs 200-day MA

-2.9%

50/200-day relationship not available

Beta (5Y)

0.29

Less volatile than the market

Sharpe ratio

0.18

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/185750

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/185750 stock rating?

krx/185750 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/185750 analysis?

The full report lives at /stocks/krx/185750/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/185750?

The latest report frames krx/185750 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/185750 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.